Cargando…

Correction: Molecular Profiling of Multiple Human Cancers Defines an Inflammatory Cancer-Associated Molecular Pattern and Uncovers KPNA2 as a Uniform Poor Prognostic Cancer Marker

Detalles Bibliográficos
Autores principales:	Rachidi, Saleh M., Qin, Tingting, Sun, Shaoli, Zheng, W. Jim, Li, Zihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897777/ http://dx.doi.org/10.1371/annotation/a8159928-d073-4b5b-8a50-c68c95b78681

Ejemplares similares

Molecular Profiling of Multiple Human Cancers Defines an Inflammatory Cancer-Associated Molecular Pattern and Uncovers KPNA2 as a Uniform Poor Prognostic Cancer Marker
por: Rachidi, Saleh M., et al.
Publicado: (2013)

Approaches to uncovering cancer diagnostic and prognostic molecular signatures
por: Hong, Shengjun, et al.
Publicado: (2014)

Correction to: Depletion of nuclear import protein karyopherin alpha 7 (KPNA7) induces mitotic defects and deformation of nuclei in cancer cells
por: Vuorinen, Elisa M., et al.
Publicado: (2019)

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Shi, Bentao, et al.
Publicado: (2015)

Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7
por: Duan, Jihui, et al.
Publicado: (2017)

Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7
por: Duan, Jihui, et al.
Publicado: (2016)

KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer
por: Alshareeda, A T, et al.
Publicado: (2015)

Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer
por: Zhou, Jingcheng, et al.
Publicado: (2016)

Integrative bioinformatics analysis of KPNA2 in six major human cancers
por: Xu, Chaobo, et al.
Publicado: (2021)

Prognostic molecular markers in early breast cancer
por: Esteva, Francisco J, et al.
Publicado: (2004)

Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance
por: Hepburn, A. C., et al.
Publicado: (2019)

Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Xu, Mingxing, et al.
Publicado: (2021)

Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
por: Suraweera, Amila, et al.
Publicado: (2021)

The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer
por: Christiansen, Anders, et al.
Publicado: (2013)

Correction to: Prognostic significance of serum inflammatory markers in esophageal cancer
por: Powell, Arfon G. M. T., et al.
Publicado: (2021)

Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer
por: Rose-James, Alphy, et al.
Publicado: (2012)

Correction: Uncovering the Differential Molecular Basis of Adaptive Diversity in Three Echinochloa Leaf Transcriptomes
Publicado: (2015)

Correction: DLPFC transcriptome defines two molecular subtypes of schizophrenia
por: Bowen, Elijah F. W., et al.
Publicado: (2019)

Molecular regulation of macrophages in unleashing cancer-related inflammation
por: Hong, Feng, et al.
Publicado: (2014)

Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets
por: Alnoumas, Layla, et al.
Publicado: (2022)

Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
por: Wang, Yuzhu, et al.
Publicado: (2018)

Correction to ‘Isospectrals of non-uniform Rayleigh beams with respect to their uniform counterparts’
por: Bhat K, Srivatsa, et al.
Publicado: (2018)

Correction: Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer
por: Di Caro, Giuseppe, et al.
Publicado: (2016)

Correction: Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer
por: Marín-Aguilera, Mercedes, et al.
Publicado: (2017)

Correction: Thermal modulation of epicardial Ca(2+) dynamics uncovers molecular mechanisms of Ca(2+) alternans
por: Millet, Jose, et al.
Publicado: (2021)

Correction: ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis
por: Park, Sunyoung, et al.
Publicado: (2019)

Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression
por: Li, Xiao-Lei, et al.
Publicado: (2013)

LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3
por: Liu, Tianyou, et al.
Publicado: (2018)

SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer
por: Wei, Zhengmao, et al.
Publicado: (2022)

Correction: Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Gastric Cancer: A Systematic Review
por: Wen, Lei, et al.
Publicado: (2014)

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2017)

MON-502 Clinical-Pathological and Molecular Prognostic Markers in Aggressive and Poorly Differentiated Thyroid Cancers; A Tertiary-Center Experience
por: Radi, Suhaib, et al.
Publicado: (2020)

Helicobacter pylori and Molecular Markers as Prognostic Indicators for Gastric Cancer in Korea
por: Kim, Hee Jin, et al.
Publicado: (2014)

Single‐cell isogrowth profiling: Uniform inhibition uncovers non‐uniform drug responses
por: Lukačišin, Martin, et al.
Publicado: (2022)

Correction: Integrating Multi-Omics for Uncovering the Architecture of Cross-Talking Pathways in Breast Cancer
por: Wang, Li, et al.
Publicado: (2019)

Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma
por: Rocha, Pedro, et al.
Publicado: (2021)

A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
por: Chen, Kenneth S., et al.
Publicado: (2016)

Molecular markers in bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Correction: Molecular profile of BRCA-mutated biliary tract cancers
Publicado: (2020)

A systems genomics approach to uncover the molecular properties of cancer genes
por: Grassmann, Felix, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cco00bgtj9ca9fitnm96bgp1tv